Disclosed CapitolDisclosedCapitol
Home
Plans
Chad AI
API
Sign InGet Pro

Never Miss a Trade

Get weekly trade alerts free.

Explore

  • Politician Trades
  • Politicians
  • Executive Branch
  • Companies
  • All Stocks A–Z
  • Leaderboard
  • Compare Politicians
  • Committee Portfolios
  • Chad AI

Money & Policy

  • Government Contracts
  • Lobbying
  • Legislation
  • Campaign Finance
  • Institutional (13F)
  • Whale Watch (13D)

Markets

  • Markets Overview
  • Top Companies
  • Insider Trends
  • Economic Indicators
  • Live News

Resources

  • API Access
  • Developers
  • Data Export
  • Glossary
  • Methodology
  • Data Sources
  • How It Works

Company

  • About Us
  • Press
  • FAQ
  • Pricing
  • vs. Capitol Trades
  • Contact
  • Watchlist

Legal

  • Editorial Standards
  • Corrections
  • Disclaimers
  • Privacy
  • Terms
© 2026 Disclosed Capitol. All rights reserved.
TermsPrivacyDisclaimer
HomeTrades
Chad
WatchlistAccount

INVA

Healthcare
Innoviva, Inc. · Biotechnology
Trades
2
Politicians
0
Buys
0
Sells
0
Trades
2
Politicians
0
Buys
0
Sells
0
INVAvs S&P 500 (normalized)
|to
No price data available
INVA S&P 500 Buy Sell
Range
PoliticianActionDescriptionAmountTradedFiled
George WhitesidesD
SellInnoviva, Inc.$250K - $500KMar 25, 2025Apr 23, 2025
George WhitesidesD
SellInnoviva, Inc.$50K - $100KMar 24, 2025Apr 23, 2025

Innoviva, Inc. (INVA) Congressional Stock Trades

This page tracks congressional stock trading activity in Innoviva, Inc. (INVA) in the Healthcare sector. Disclosed Capitol has indexed 2 disclosed congressional trades involving INVA. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.

As of April 2025 — Disclosed Capitol has tracked 2 disclosed congressional trades in Innoviva, Inc. (INVA) — no buy-to-sell ratio on file yet — led by George Whitesides (D).

Which members of Congress trade Innoviva, Inc.?

  • George Whitesides (D) — 2 disclosed trades in INVA

Recent INVA congressional trades

DatePoliticianPartyActionAmount
Mar 25, 2025George WhitesidesDSell$250,001 - $500,000
Mar 24, 2025George WhitesidesDSell$50,001 - $100,000

Buy vs. sell ratio & volume

Across the 2 disclosed congressional trades in Innoviva, Inc. (INVA), members of Congress have reported 0 buys and 0 sells. The average 30-day alpha vs. the S&P 500 is -0.01%.

Are Innoviva, Inc. insiders buying or selling INVA?

As of August 2026, corporate insiders at Innoviva, Inc. have filed 3 SEC Form 4 transactions in INVA over the past 12 months.

DateInsiderActionValue
2026-08-20Zhen Marianne — Chief Accounting OfficerTax Withholding$24K
2026-08-20Basso Stephen — Chief Financial OfficerTax Withholding$12K
2026-08-20Raifeld Pavel — Chief Executive OfficerTax Withholding$24K

Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.

Innoviva, Inc. financial snapshot (FY2025)

For fiscal year 2025, Innoviva, Inc. reported revenue of $411.3M and net income of $271.2M, per SEC filings.

Revenue
$411.3M
Gross profit
$307.7M
Operating income
$163.7M
Net income
$271.2M
Diluted EPS
$3.30
Gross margin
74.8%
Net margin
65.9%
Free cash flow
$195.8M

Most recent reported quarter: Q2 FY2026 — revenue $119.6M, net income -$83.4M.

Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.